We serve Chemical Name:2-aminotoluene-5-sulfonic acid CAS:34598-33-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-aminotoluene-5-sulfonic acid
CAS.NO:34598-33-9
Synonyms:Undecanoic acid, 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-;EINECS 252-108-4;2H,2H,3H,3H-Heptadecafluoroundecanoic Acid;4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoroundecanoic acid;MFCD00025198;2H,2H,3H,3H-Perfluoroundecanoic Acid
Molecular Formula:C11H5F17O2
Molecular Weight:492.129
HS Code:2915900090
Physical and Chemical Properties:
Melting point:93-97ºC
Boiling point:244.9±35.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.308
PSA:37.30000
Exact Mass:492.001801
LogP:6.86
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Undecanoic acid, 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2H,2H,3H,3H-Perfluoroundecanoic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 252-108-4 Use and application,EINECS 252-108-4 technical grade,usp/ep/jp grade.
Related News: “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 2-Thiophenecarboxylic acid, 5-[4-(nonyloxy)phenyl]-,4-[[[(1S)-1-methylheptyl]oxy]carbonyl]phenyl ester manufacturers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 2-Isopropyl-7-oxo-7H-furo[3,2-g]chromene-9-sulfonic acid acridin-9-ylamide suppliers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 3-hydroxy-3-methylisoindolin-1-one vendor & factory RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO,RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO
